Raymond Pratt's most recent trade in Savara Inc was a trade of 280,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Savara Inc | Raymond Pratt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Savara Inc | Raymond Pratt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 80,000 | 340,050 (0%) | 0% | 0 | Common Stock | |
| Savara Inc | Raymond Pratt | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.97 per share. | 10 Nov 2024 | 49,950 | 260,050 (0%) | 0% | 4.0 | 198,302 | Common Stock |
| Savara Inc | Raymond Pratt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 150,000 | 310,000 (0%) | 0% | 0 | Common Stock | |
| Savara Inc | Pratt Raymond | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Savara Inc | Raymond Pratt | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.93 per share. | 26 Jun 2023 | 6,500 | 160,000 (0%) | 0% | 2.9 | 19,045 | Common Stock |
| Savara Inc | Raymond Pratt | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 22 Dec 2022 | 3,500 | 153,500 (0%) | 0% | 1.5 | 5,402 | Common Stock |
| Savara Inc | Raymond Pratt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) | |
| Savara Inc | Raymond Pratt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 150,000 | 150,000 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Raymond Pratt | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 112,500 | 112,500 | - | - | Stock Option (Right to Buy) |